Viewing nowEsome 20mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 22.25mg
Tablet · Prescription medication
LNC Bio Co., Ltd.

MFDS item code 202003714 · Approved 2020.05.21 · Insurance code 060500810
Treatment and prevention of gastric disorders caused by excess stomach acid (including reflux), ulcers and Helicobacter pylori infection, and gastrointestinal disorders caused by anti-inflammatory analgesics
This medication is used for the treatment of gastroesophageal reflux disease, especially reflux esophagitis, and for long-term maintenance therapy to prevent recurrence in esophagitis patients. It is also effective in alleviating symptoms of gastroesophageal reflux disease without esophagitis. It is used in combination with antibiotics for the eradication of Helicobacter pylori and helps in the treatment and prevention of recurrence of duodenal and peptic ulcers caused by H. pylori. It is also effective in treating upper gastrointestinal symptoms and gastric ulcers associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs), as well as preventing gastric and duodenal ulcers. It is widely used in the treatment of Zollinger-Ellison syndrome and prevention and maintenance therapy of rebleeding from gastric or duodenal ulcers. This medication is used for the treatment of various gastrointestinal-related diseases and symptom relief.
This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, take it for an additional 4 weeks. 20 mg once daily 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. Adults may take 20 mg once daily as needed. For patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug therapy, as-needed administration is not recommended for controlling recurring symptoms. Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Clinical studies longer than 4 weeks have not been conducted. 20 mg once daily. The treatment period is 4∼8 weeks. 20 mg once daily. The recommended initial dose is 40 mg twice daily. Subsequent doses should be adjusted individually, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses of 80 mg or more daily should be divided into 2 doses. Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection. No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal failure. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. No dose adjustment is necessary.
Adolescents aged 12 years and older — Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, take it for an additional 4 weeks. Adolescents aged 12 years and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Adolescents aged 12 years and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. Children under 12 years of age — There is no experience with administering this medicine to children under 12 years of age.
This medication should not be administered to patients who are hypersensitive to certain components or have previously experienced allergic reactions. It is also safe to avoid administration in patients currently taking certain antibiotics or antivirals, those with a history of myocardial infarction, and nursing women. This medication contains Yellow No. 5, so those allergic to this component should use it with caution. During treatment, various side effects such as headaches, dizziness, dyspepsia, skin rashes, and muscle pain may occur, so if any unusual symptoms arise, consult a doctor immediately. Especially with long-term use, there are risks of hypomagnesemia, increased fracture risk, and gastrointestinal infections, so regular monitoring is necessary. This medication may interact with other drugs, so it is essential to inform healthcare professionals about any concomitant medications, and dose adjustment or discontinuation may be necessary with certain medications. Pregnant or nursing women should consult a physician before taking this medication. In cases of overdose, there is no specific antidote, so it is crucial to go to the hospital immediately for appropriate treatment, and it is important to keep it out of reach of children. Also, transferring the medication to other containers is not advisable for maintaining quality.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylaxis, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucination, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, eosinophilia with systemic symptoms drug reaction, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, hepatic dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatic polymyalgia, anorexia, apathy, increased appetite, confusion, exacerbation of depression, hypertonicity, sensory impairment, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, visual field loss, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, dysosmia, ageusia, gustatory distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, voiding frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is important to maintain the storage temperature between 1 and 30 degrees Celsius to preserve the medication's effectiveness.
Pale pink round film-coated tablet
28 tablets/box [(14 tablets/Alu-Alu × 2)], 30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 22.25mg
Tablet · Prescription medication
LNC Bio Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.